ZENITH Expands US Presence
News Aug 19, 2016
ZENITH Technologies is expanding its US presence by opening two new offices on the West Coast of the US to meet greater demand for its automation, process control and serialization technology support services.
Marking 10 years since the company first opened a US base in Pennsylvania, the new sites in Oakland and San Diego will help the life science technology firm deliver a more localized service to its North American customers.
Zenith Technologies’ clients range from small and mid-sized pharma and biotech companies to contract manufacturing organisations and big pharma firms.
The decision to open the new offices comes following an increase in demand for its automation manufacturing software systems and the significant biotech sector expansions in Southern and Northern California.
Mike Smith, US sales manager at Zenith Technologies said: “We are looking forward to bolstering our US presence with the opening of these two new sites as it means we can provide complete coverage of service in the US from coast to coast.
“Expanding into such high growth areas for the life science and biotechnology industry means it is a really exciting time for our company and a great way to mark a decade of presence in North America.”
Both offices will act as a hub for critical project aid, back office assistance and managed services, allowing Zenith Technologies to provide improved service and on-the-ground support to its customer base.
The company’s US expansion initially began as a single project in Pennsylvania in 2006 but has grown into six offices across the US and close to 100 employees servicing a diverse client base.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE